(Last updated : 2026-09-03 10:42:24)
  Akira Hirano
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of Nephrology and Hypertension,
   Position   Instructor
■ Current specialization
Nephrology 
■ Journal Articles
1. 2026/07/13 Sequential Management Enabling Continuation of Peritoneal Dialysis in Autosomal Dominant Polycystic Kidney Disease Despite Multiple Complications 
2. 2026/04 Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease 
3. 2026/01/01 Endothelial dysfunction accelerates AKI to CKD transition by promoting β-catenin activation in macrophages  Link
4. 2026 Unexpected drainage failure in a patient receiving long-term peritoneal dialysis. 
5. 2025/11/06 The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria 
Display all(10)
■ Presentations
1. 2026/03/30 Association Between serum potassium levels and CKD Progression in Japan: A Retrospective Cohort Study Using the J-CKD-DB-Ex Registry (Poster notice,General) 
2. 2026/03/30 ASSOCIATION BETWEEN SYSTEMIC INFLAMMATION AND CHRONIC KIDNEY DISEASE PROGRESSION IN JAPAN: A RETROSPECTIVE
COHORT STUDY USING THE J-CKD-DB-EX REGISTRY (Poster notice,General) 
3. 2026/03/29 Effects of Non-steroidal Mineralocorticoid Receptor Blocker Esaxerenone on Glomerular Hemodynamics in type 2 Diabetic Kidney Disease (Poster notice,General) 
4. 2026/03/29 PROTECTIVE ROLE OF FINERENONE AGAINST PODOCYTE INJURY THROUGH MR–TRPC PATHWAY INHIBITION IN DIABETIC KIDNEY
DISEASE (Poster notice,General) 
5. 2025/11/08 Mineralocorticoid Receptor-TRPC5 Axis Drives Macrophage-Mediated Inflammation in Diabetic Kidney Disease (Speech,General) 
Display all(11)